Medexus Pharmaceuticals Inc. (MDP.TO) TSX

Currency In CAD

AD

Valuation

Market Cap100.83M
Enterprise Value116.57M
P/E Ratio-47.26
PEG Ratio1.07
Price/Sales Ratio1.17
Price/Book Ratio2.39
Enterprise/Revenue1.33
Enterprise/EBITDA10.46

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.02
Operating Margin0.06
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue99.33M
Revenue/Share3.1
Gross Profit54.41M
EBITDA12.66M
Net Income-2.39M
Diluted EPS-0.07

Balance Sheet

Total Cash6.52M
Total Cash/Share0.2
Total Debt22.26M
Total Debt/Equity0.45
Current Ratio1.19
Book Value Per Share1.53

Price History

52-Week Change76.53
52-Week High5.25
52-Week Low2.47
Moving Average 50 Days4.18
Moving Average 200 Days3.28

Statistics

Average Volume47,420
Shares Outstanding31.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateDecember 19, 2018
AD